1[1]Kranzhofer R, Schmidt J, Pferffer CAH, et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol, 1999,19:1623-1629. 被引量：1
2[2]Chen H, Li D, Mehta JL. Attenuation of tissue P-selectin and MCP-1 excpression and intimal proliferation by AT1 receptor blockade in hyperlipidemic rabbits[J].Biochem Biophy Res Commun, 2001,282:474. 被引量：1
3[3]Li J, Hirose N, Kawamura M, et al. Antiatherogenic effect of angiotensin converting enzyme inhibiter and angiotensin 11 receptor antagonist in the cholesterol fed rabbits[J].Atherosclerosis,1999,143:315-326. 被引量：1
4[4]Fennessy PA, Campbell JH, Mendelsohn FA, et al. Angiotensin-converting enzyme inhibitors and atherosclerosis:relevance of animal models to human disease[J]. Clin Exp Pharmacol Physiol, 1996,23:s30-s32. 被引量：1
5[5]Keidar S, Attias J, Smith J, et al. The angiotensin Ⅱ receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice[J]. Biochem Biophys Res Commun, 1997,236:622-625. 被引量：1
6[6]Miyazaki M, Sakonjo H, Takai S, et al. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin 11 antagonist in cynomolgus monkeys fed a high cholesterol diet[J]. Br J Pharmacol, 1999,128:523-529. 被引量：1
